Alios BioPharma
Latest round
- Series B
Last raised
- May 2014
Total raised
- $52M
Investors
- 5
About Alios BioPharma
Alios BioPharma Inc. is a biopharmaceutical company focused on developing innovative therapeutics for serious viral infections., founded in 2006 and headquartered in San Francisco, US, specializes in virology therapeutics.75 billion, marking a significant strategic expansion by the parent company. The acquisition aimed to bolster Johnson & Johnson's portfolio in the field of infectious diseases.Alios BioPharma Inc. develops therapies primarily targeting serious viral infections, contributing to the healthcare sector by providing advanced medical solutions.Alios BioPharma's revenue is generated through its innovative therapeutic solutions aimed at addressing viral infections, with a strong focus on partnerships with healthcare organizations.The recent acquisition by Johnson & Johnson highlights a commitment to leveraging Alios BioPharma's expertise in virology.75 billion acquisition to fuel research and development initiatives. Strategic plans include exploring additional international markets and enhancing treatment technologies in the coming years.
Who invested in Alios BioPharma
5 investors across 3 rounds
See all investors in Alios BioPharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alios BioPharma
Who invested in Alios BioPharma?
Alios BioPharma has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alios BioPharma raised?
Alios BioPharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Alios BioPharma last raise money?
Alios BioPharma's most recent round on record is a Series B, in May 2014.
What does Alios BioPharma do?
Alios BioPharma is a biotechnology company.
Where is Alios BioPharma headquartered?
Alios BioPharma is headquartered in San Francisco, US.
Which VCs invest in companies like Alios BioPharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Alios BioPharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Alios BioPharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.